Get our newsletter delivered directly to your inbox
I have already subscribed | Do not show this message again
Your email has been successfully registered.
During the next three weeks, 900 random people from 19 to 80 years old will receive two doses of this vaccine.
Cuba's Soberana 02 vaccine Tuesday began phase II B of its clinical trials in the Revolution Square and La Lisa, two Havana municipalities that are considered high-risk territories for the COVID-19 transmission.
During the next three weeks, the 19 de Abril and Clinica Uno health care centers will administer two doses of the intramuscular vaccine to 900 people from 19 to 80 years old.
The volunteers signed a document offering their consent to take part in the clinical trial. In this phase, health authorities will test the reactions, safety, and immunity of the COVID-19 vaccine created by the Cuban Finlay Institute.
"If the results of the phase II B are positive, the vaccine will pass to the third phase, which is decisive to determine if it can be massively used," the specialist of the Pedro Kouri Tropical Medicine Insititute, Maria Toledo, explained.
Cuban doctors and the Cuban people set themselves apart as continually making a positive contribution to the lives of people world wide, nearly always at great risk to themselves https://t.co/ch7pU0trfA